Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol.
about
Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraceptionContinuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraceptionSafety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptivesContraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled studyExtended regimen combined oral contraception: A review of evolving concepts and acceptance by women and cliniciansPerspectives of breast cancer etiology: synergistic interaction between smoking and exogenous hormone use.Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women.New low-dose, extended-cycle pills with levonorgestrel and ethinyl estradiol: an evolutionary step in birth control.The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μgContraceptive failure related to estimated cycle day of conception relative to the start of the last bleeding episode.Contraceptive hormone use and cardiovascular diseaseExtended- and continuous-cycle oral contraceptives.The creeping Pearl: Why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills?Venous thromboembolism in women.Efficacy of contraceptive methods: A review of the literature.Extended and continuous combined contraceptive regimens for menstrual suppression.Hormone withdrawal-associated symptoms: overlooked and under-explored.Extended regimens of combined hormonal contraception to reduce symptoms related to withdrawal bleeding and the hormone-free interval: a systematic review of randomised and observational studies.European society of contraception statement on contraception in obese women.Extended-Cycle Levonorgestrel/Ethinylestradiol and Low-Dose Ethinylestradiol (Seasonique(®)): A Review of Its Use as an Oral Contraceptive.Differences in reporting Pearl Indices in the United States and Europe: Focus on a 91-day extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.Cycle control with an extended-regimen oral contraceptive combining levonorgestrel and ethinyl estradiol that includes continuous low-dose ethinyl estradiol instead of the traditional hormone-free interval.Extended-cycle oral contraceptive pills with 10 microg ethinyl estradiol pills in place of placebo pills.Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe.A comparison of the pharmacokinetic profile of an ascending-dose, extended-regimen combined oral contraceptive to those of other extended regimens.A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.Contraceptive efficacy and safety of estradiol valerate/dienogest in a healthy female population: a multicenter, open-label, uncontrolled Phase III study.
P2860
Q24194774-CD2369A7-A83B-419C-8A60-5AD60C2DD409Q24246655-866A2576-8C65-4D56-AD7C-D9515205730FQ28265684-FD38241C-DDFB-4097-9F89-1E5992893CC1Q28384507-66170506-8E68-41AA-B30C-006151E9EC8BQ28392784-C8DB2730-32CF-4E26-8886-0D39BB80C37DQ33579730-A56D8938-13AD-47AA-B48A-D6F2617377FBQ34050164-2CDA8416-014F-4CF3-AA21-4C6AC3807546Q34272169-5E953A8B-E5AE-4330-A66F-9A53C7ABF921Q34345598-8C0E134D-D4FC-43FA-B30A-7BB20992B0F7Q36873346-370275DE-D32E-43E0-82D8-5B622FC63A59Q37138852-1EA40FCC-4543-4534-A90C-AD94BD0FABFDQ37227517-9632B114-8BB4-48DB-8F9B-4BF91EDC38DEQ37227518-B6F15BC2-CBAD-4F8F-BFDF-69D3FC41F101Q37238147-9C754188-FA9D-4098-9AC5-A2B650D27E79Q37688124-55A31E07-6B75-43DF-9D49-9371D0F7A288Q38065342-FA307CFE-80B1-4939-B9DA-1833A47A18DDQ38082793-0198732F-1DE7-4879-AD55-35D52484777AQ38223794-22B99468-969A-4B8C-8207-68CAF0AA7881Q38266121-470C5C27-4B61-4026-B6B0-BA34CB94EC0CQ38504635-AC8E60D9-A014-41D8-A7CE-86509075DA5BQ40793097-E0400AE8-E65E-43DD-988D-FA48F4F4E40DQ42373199-C617D916-6E32-4265-AD7E-A511BCCF1E78Q43267022-7698FCCB-20D9-4A03-9824-CC4DD3F7C1B3Q44080622-A5D50AB5-C9E3-4C17-BD5C-AA3B7582B8A5Q51101026-252F251C-D8C2-4F49-9B6E-7DB8C0DE8979Q53658082-D410D99E-B830-451E-B0C8-1F25B3747215Q55331272-941AE6D3-DF9E-4213-85C3-63EA77F21889
P2860
Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Safety and efficacy of an exte ...... us low-dose ethinyl estradiol.
@en
Safety and efficacy of an exte ...... us low-dose ethinyl estradiol.
@nl
type
label
Safety and efficacy of an exte ...... us low-dose ethinyl estradiol.
@en
Safety and efficacy of an exte ...... us low-dose ethinyl estradiol.
@nl
prefLabel
Safety and efficacy of an exte ...... us low-dose ethinyl estradiol.
@en
Safety and efficacy of an exte ...... us low-dose ethinyl estradiol.
@nl
P2093
P1433
P1476
Safety and efficacy of an exte ...... us low-dose ethinyl estradiol.
@en
P2093
David Portman
Freedolph D Anderson
William Gibbons
P304
P356
10.1016/J.CONTRACEPTION.2005.09.010
P577
2005-11-02T00:00:00Z